Furthermore, hormonal variations and cytokine levels may contribute to PKM2 regulation, given their known effects on metabolic enzyme expression Therefore, the differences in PKM2 activation between the GDM-I and GDM-D placentas may stem from both treatment-induced metabolic shifts and underlying insulin resistance severity. The gene discussed is PKM; the disease is Insulin resistance.